Freedom of Information Request: 0677 2019/20
Could you kindly provide the answers to the questions mentioned below for Ophthalmology and number of patients treated for the last 12 months with mentioned drugs.
- Within your trust how many patients over the last 12 months have received treatment with an anti VEGF therapy, who had not previously had anti VEGF therapy?
We do not hold this information in a format that allows us to easily identify patients who received VEGF therapy in the last 12 months who have not previously received it.
We would need to review individual patient records which would be in breach of the second data protection principle “Personal information must be processed for limited purpose”. We are therefore withholding this information under Section 40 of the Freedom of Information Act.
- How many of these [from question 1] patients have received the following anti VEGF therapy in the last 12 months?
Ranibizumab
Bevacizumab
Aflibercept
Fluocinolone
Dexamethasone
N/A
- Of the patients above, how many were treated for Wet Age Related Macular Degeneration (wAMD)?
Ranibizumab
Bevacizumab
Aflibercept
Fluocinolone
Dexamethasone
N/A
